What Causes Tardive Dyskinesia? The Truth Might Shock You!
Tardive dyskinesia is a medical condition that has been shrouded in misunderstanding for years. This article aims to shed light on the crucial factors that cause this disease and the viable treatments available in places like Edmonton, USA, and beyond.
What is Tardive Dyskinesia?
Tardive dyskinesia is a neurological disorder characterized by involuntary, repetitive body movements. It typically results from prolonged use of antipsychotic medications, specifically those used for treating mental illnesses like schizophrenia and bipolar disorder. However, the exact cause of tardive dyskinesia remains a topic of ongoing research.
The Real Culprits: Antipsychotic Medications
While the exact cause of tardive dyskinesia is unknown, it’s widely accepted that long-term use of certain antipsychotic medications is a significant risk factor. These drugs block dopamine receptors in the brain, which can eventually lead to abnormal motor function. This is particularly true for older, “first-generation” antipsychotics. However, even “second-generation” or “atypical” antipsychotics, which were initially thought to carry a lower risk, can still cause tardive dyskinesia.
Understanding Active Crohn’s Role
Interestingly, there are reported cases of tardive dyskinesia among patients with active Crohn’s disease. Crohn’s disease is an inflammatory bowel disease marked by inflammation of the digestive tract. While the connection between these two conditions is not entirely understood, it further emphasizes the complexity of tardive dyskinesia’s causes.
Recognizing Tardive Dyskinesia: Signs and Treatments
Tardive dyskinesia’s symptoms can range from mild twitching to more severe uncontrolled movements. Common signs include grimacing, lip smacking, eye blinking, and rapid movement of the arms and legs.
In Edmonton and throughout the USA, treatment for tardive dyskinesia often involves changes in medication. In some cases, doctors may reduce the dosage or switch to a different antipsychotic drug. Additionally, two medications specifically designed to treat tardive dyskinesia - valbenazine and deutetrabenazine - have been approved by the FDA.
Tardive Dyskinesia Treatment in the USA
In the USA, the approach to tardive dyskinesia treatment is multidimensional, focusing not only on medication but also on patient education, regular monitoring, and lifestyle modifications. The goal is to manage symptoms while minimizing the risks associated with antipsychotic drugs.
The Journey to Understanding: An Ongoing Process
As we continue to delve deeper into the causes and treatment of tardive dyskinesia, it’s clear that this is a complex condition with many contributing factors. While antipsychotic medications are a known risk, other elements, such as the potential link with active Crohn’s disease, remind us of the intricate nature of the human body and the diseases that affect it. By continuing to pursue knowledge and understanding, we can hope to provide better care for those living with tardive dyskinesia.
